Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $346.33 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $124.99 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $117.64 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $90.00 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $13.70 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.70 | 1 | Janssen Biotech, Inc. ($13.70) |
| 2023 | $242.63 | 2 | AbbVie Inc. ($124.99) |
| 2022 | $90.00 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($90.00) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Immunology | ||||||
| 11/02/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $117.64 | General |
| Category: Neuroscience | ||||||
| 04/18/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/29/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 15 | $2,850 | $1,488 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 15 | $2,850 | $1,488 | 52.2% |
About Dr. Joshua Soliman, MD
Dr. Joshua Soliman, MD is a Gastroenterology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2019. The National Provider Identifier (NPI) number assigned to this provider is 1144783945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Soliman, MD has received a total of $346.33 in payments from pharmaceutical and medical device companies, with $13.70 received in 2024. These payments were reported across 4 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($346.33).
As a Medicare-enrolled provider, Soliman has provided services to 15 Medicare beneficiaries, totaling 15 services with total Medicare billing of $1,488. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Fort Myers, FL
- Active Since 04/09/2019
- Last Updated 09/12/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144783945
Products in Payments
- SKYRIZI (Biological) $124.99
- ZEPOSIA (Drug) $117.64
- ENTYVIO (Biological) $90.00
- STELARA (Biological) $13.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Myers
Randall Jacobs, Md, MD
Gastroenterology — Payments: $18,306
Juan Tejada-Almonte, M.d, M.D
Gastroenterology — Payments: $13,404
Dr. Augustine Salami, Md, MD
Gastroenterology — Payments: $10,902
Dr. Edward Jurkovic, D.o, D.O
Gastroenterology — Payments: $9,721
Robert Janda, Md, MD
Gastroenterology — Payments: $8,904
David Elliott, Do, DO
Gastroenterology — Payments: $8,680